https://orcid.org/0000-0002-8791-0167
Figures & data
Figure 1. A diagrammatic overview of the positive and negative influence of gut bacteria represented across a wide-range of health and disease conditions.
Figure 2. Annual (top) and cumulative (bottom) trend of published research manuscripts indexed on MEDLINE/PubMed matching the terms ‘probiotics’ AND (‘health’ OR ‘disease’) [data refer to search conducted on 27 November 2018].
![Figure 2. Annual (top) and cumulative (bottom) trend of published research manuscripts indexed on MEDLINE/PubMed matching the terms ‘probiotics’ AND (‘health’ OR ‘disease’) [data refer to search conducted on 27 November 2018].](/cms/asset/c99f4886-19d5-49c0-a14a-f02ba1bc32bd/ifso_a_12364185_f0002.jpg)
Figure 3. Overview of multi-omics technologies and associated analytical techniques.
GC: Gas chromatography; HPLC: High-performance liquid chromatography; LC-MS: Liquid chromatography–mass spectrometry; MALDI: Matrix-assisted laser desorption ionization; MS: Mass spectrometry; NGS: Next-generation sequencing; NMR = nuclear magnetic resonance.
Figure 4. A schematic drawing to demonstrate gut bacterial metabolism of dietary components choline and L-carnitine into TMA which is subsequently converted to TMAO by liver flavin-containing monooxygenases (e.g., FMO3).
TMA: Trimethylamine; TMAO: Trimethylamine N-oxide.
